BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Access the interviews in their entirety at:
BIVI: https://www.redchip.com/assets/access/bivi_accessLBSR: https://www.redchip.com/assets/access/lbsr_access
In an exclusive interview, Cuong Do, President and CEO of BioVie, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share how BioVie is unlocking the science of longevity through novel therapeutics targeting neurodegenerative diseases and advanced liver conditions. Do highlights the Company's lead drug candidate, bezisterim, a first-in-class small molecule designed to combat chronic inflammation and insulin resistance-key drivers in Alzheimer's and Parkinson's disease, as well as Long COVID. He also discusses BIV201, BioVie's Orphan-designated liver therapy being developed to treat - and may become the first approved treatment - for ascites, an end-stage liver disease condition of 50%+ mortality rate in 12 months. With multiple clinical programs advancing across Phase 2 and Phase 3 trials and a clear path toward commercialization, BioVie is positioned at the forefront of transformative healthcare innovation.
Pete O'Heeron, Chairman of Liberty Star, and Liberty Star board member Gerardo King, appear on the RedChip Small Stocks Big Money™ show on Bloomberg TV to highlight the Company's dual-track strategy targeting high-grade gold and large-scale copper-gold mineralization in Arizona. They discuss recent bonanza-grade assay results from the Red Rock Canyon Gold Project, where surface samples have returned values as high as 107.5 g/t gold, and the validation of a porphyry copper system at the Hay Mountain Project through Liberty Star's 2024 drill campaign. With gold prices near all-time highs and copper demand surging amid global electrification, Liberty Star is actively pursuing a joint venture to accelerate project development while minimizing shareholder dilution. The company's experienced leadership and strategic positioning in one of North America's most prolific mining regions underscore its potential to unlock significant value through near- and long-term exploration success.
BIVI and LBSR are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About BioVie Inc.
BioVie Inc. (NASDAQ:BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Long COVID, Alzheimer's disease and Parkinson's disease) and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-kB, and the associated neuroinflammation and insulin resistance but not ERK and NFkB homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of AD and PD. Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of Long COVID. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated and discussed with guidance received from the FDA regarding the design of Phase 3 clinical testing of BIV201 for the reduction of further decompensation in participants with liver cirrhosis and ascites. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com.
About Liberty Star
Liberty Star Uranium & Metals Corp. (LBSR:OTCQB), d/b/a Liberty Star Minerals, is an Arizona-based mineral exploration company engaged in the acquisition, exploration, and development of mineral properties in Arizona and the southwest USA. Currently the company controls properties that are located over what management considers some of North America's richest mineralized regions for copper, gold, silver, molybdenum (moly), and associated metals. The Company's premiere property is the Hay Mountain property (exploration stage) for porphyry copper, gold, moly and other commercially important minerals. Specific targets have been selected to explore for near-surface and deep-seated ore bodies, of which there are numerous analogs nearby. Contiguous with the primary Hay Mountain porphyry exploration target, and part of the overall Hay Mountain property, is an increasingly attractive area of exploration stage gold mineralization denominated Red Rock Canyon. Red Rock Canyon exhibits what we believe are extensive, promising hydrothermal associated gold-bearing structures that are documented in historical public and Company records. View numerous geoscientific reports on our website. The Hay Mountain & Red Rock Canyon properties are in Cochise County (southeast) Arizona, USA.
Follow Liberty Star Minerals on Facebook, LinkedIn & [X]Twitter
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave GentryRedChip Companies Inc.1-407-644-4256info@redchip.com
--END--
SOURCE: RedChip Companies, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Earnings To Watch: NMI Holdings (NMIH) Reports Q2 Results Tomorrow
Mortgage insurance provider NMI Holdings (NASDAQ:NMIH) will be reporting results this Tuesday after the bell. Here's what you need to know. NMI Holdings beat analysts' revenue expectations by 3% last quarter, reporting revenues of $173.2 million, up 10.9% year on year. It was an exceptional quarter for the company, with a solid beat of analysts' net premiums earned estimates and a solid beat of analysts' EPS estimates. Is NMI Holdings a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting NMI Holdings's revenue to grow 7.6% year on year to $174.4 million, slowing from the 13.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.19 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. NMI Holdings has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 1.2% on average. Looking at NMI Holdings's peers in the property & casualty insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Stewart Information Services delivered year-on-year revenue growth of 20.1%, beating analysts' expectations by 9.2%, and First American Financial reported revenues up 14.2%, topping estimates by 4.9%. Stewart Information Services traded up 10.3% following the results while First American Financial was also up 3.5%. Read our full analysis of Stewart Information Services's results here and First American Financial's results here. Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the property & casualty insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. NMI Holdings is down 9.9% during the same time and is heading into earnings with an average analyst price target of $43.71 (compared to the current share price of $38). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
FTAI Aviation Earnings: What To Look For From FTAI
Aircraft leasing company FTAI Aviation (NASDAQ:FTAI) will be announcing earnings results this Tuesday after market close. Here's what you need to know. FTAI Aviation missed analysts' revenue expectations by 2.1% last quarter, reporting revenues of $502.1 million, up 53.7% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' EBITDA estimates but a significant miss of analysts' adjusted operating income estimates. Is FTAI Aviation a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting FTAI Aviation's revenue to grow 42.2% year on year to $630.6 million, slowing from the 61.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.39 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. FTAI Aviation has missed Wall Street's revenue estimates three times over the last two years. Looking at FTAI Aviation's peers in the industrial distributors segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Fastenal delivered year-on-year revenue growth of 8.6%, beating analysts' expectations by 0.5%, and Richardson Electronics reported revenues up 9.5%, falling short of estimates by 3.7%. Fastenal traded up 4.2% following the results while Richardson Electronics was also up 10.9%. Read our full analysis of Fastenal's results here and Richardson Electronics's results here. There has been positive sentiment among investors in the industrial distributors segment, with share prices up 6.8% on average over the last month. FTAI Aviation's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $167.26 (compared to the current share price of $115.00). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
an hour ago
- Yahoo
Earnings To Watch: Arch Capital Group (ACGL) Reports Q2 Results Tomorrow
Insurance and reinsurance provider Arch Capital Group (NASDAQ:ACGL) will be reporting results this Tuesday after market close. Here's what you need to know. Arch Capital Group beat analysts' revenue expectations by 1% last quarter, reporting revenues of $4.67 billion, up 18.6% year on year. It was a strong quarter for the company, with a solid beat of analysts' net premiums earned estimates and an impressive beat of analysts' EPS estimates. Is Arch Capital Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Arch Capital Group's revenue to grow 10.1% year on year to $4.65 billion, slowing from the 33.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.30 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Arch Capital Group has missed Wall Street's revenue estimates twice over the last two years. Looking at Arch Capital Group's peers in the insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. RenaissanceRe delivered year-on-year revenue growth of 13.4%, beating analysts' expectations by 8.7%, and Stewart Information Services reported revenues up 20.1%, topping estimates by 9.2%. RenaissanceRe's stock price was unchanged after the resultswhile Stewart Information Services was up 10.3%. Read our full analysis of RenaissanceRe's results here and Stewart Information Services's results here. The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. Arch Capital Group is down 1.2% during the same time and is heading into earnings with an average analyst price target of $110.21 (compared to the current share price of $89.99). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
